Clinical Trial: Medicare Anti-A? mAb Coverage With Evidence Development (CED) Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mild Alzheimer's Disease
Study Type: OBSERVATIONAL
Official Title: Prospective Study on Anti-Amyloid-? Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Coverage of Evidence Development (The Anti-A? mAb CED Study)
Brief Summary:
The Anti-A? mAb CED Study is a prospective, longitudinal coverage with evidence development (CED) study using clinical data, patient assessments, and administrative claims data of the Medicare population, conducted in accordance to the National Coverage Determination (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (AD).
Read more